Brown: Risk Weighti...
Health Care: Drugs
Ampio Pharmaceuticals Inc. (AMPE: NASDAQ)
$5.03 0.03 | 0.60%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -11.59M | -18.36M | -8.05M | -26.05K |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 5.71K | 1.55K | 0.00 |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 570.50K | 166.17K | 385.01K | 4.67K |
| (Decrease) Increase In Other Current Liabilities | 0.00 | -529.48K | 471.62K | 0.00 |
| (Increase) Decrease In Other Working Capital | -50.00K | 397.22K | 193.82K | 0.00 |
| Other Non-Cash Items | 1.42M | 9.13M | 4.43M | 0.00 |
| Net Cash From Continuing Operations | -9.72M | -9.13M | -2.63M | -21.38K |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -9.72M | -9.13M | -2.63M | -21.38K |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | 0.00 | -84.70K | 0.00 | 0.00 |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 15.00K | -35.00K | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 15.00K | -119.70K | 0.00 | 0.00 |
| Issuance of Debt | 0.00 | 382.00K | 2.01M | 19.12K |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 17.54M | 22.44M | 1.37M | 0.00 |
| Repayment of Long-Term Debt | 0.00 | -100.00K | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -1.52M | -2.78M | -150.00K | 0.00 |
| Net Cash From Financing Activities | 16.02M | 19.94M | 3.23M | 19.12K |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 6.32M | 10.69M | 599.30K | -2.26K |
Portfolios with AMPE
- Portfolio NameUser Type
- UserFlying Monkey King's Actuals
- ContributorStocks Under-$10 Setting Up...
- UserFirst Try
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
Latest AMPE Headlines from TheStreet
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Ampio's Eye Drug Trial Design Won't Pass FDA Muster 04.02.13 | 09:04 am
- 5 Stocks Under $10 Set to Soar 09.20.12 | 01:09 pm
- A Biotech Short Seller Responds To Critics 07.17.12 | 08:07 am
- Ampio Insiders, Aided by PR Blitz, Soon Free to Sell Millions of Shares 07.02.12 | 01:07 pm
- Biotech Stock Mailbag: Osiris, Arena, Ampio 06.22.12 | 06:06 am
- Ampio Spins A Tale of Curing Blindness 06.11.12 | 03:06 pm
- Biotech Stock Mailbag: Ampio, Cel-Sci and Ziopharm 04.05.12 | 05:04 am
- 6 Stocks Under $10 Moving Higher 12.14.11 | 01:12 pm
Press Releases for AMPE
- Ampio Pharmaceuticals Announces Participation At The UBS Global Healthcare Conference - PR Newswire 05.13.13 | 08:05 am
- Ampio Pharmaceuticals Completes Enrollment In Run-In SPRING Study Of Ampion In Osteoarthritis Of The Knee - PR Newswire 04.25.13 | 08:04 am
- Ampio Receives FDA Clearance To Initiate Clinical Trial Of Ampionâ¿¢ For The Treatment Of Osteoarthritis Of The Knee: Patient Treatments Have Begun. - PR Newswire 04.02.13 | 04:04 am
- Ampio Receives FDA Acceptance Of Its Patient Outcome For Premature Ejaculation (POPE) Questionnaire, Paving The Way For Its US Pivotal Trial On Zertaneâ¿¢ - PR Newswire 03.11.13 | 04:03 am
- Ampio Pharmaceuticals Initiates Clinical Trial Of Optinaâ¿¢ In Diabetic Macular Edema (DME): First Patient Dosed - PR Newswire 02.27.13 | 04:02 am
- Ampio Pharmaceuticals Modifies Ampionâ¿¢ IND For Osteoarthritis Of The Knee To Include A Dose Escalation Run-In Study And Prepares To Launch Pivotal Clinical Trial - PR Newswire 02.25.13 | 04:02 am
- Ampio Forms Luoxis Diagnostics To Commercialize ORP Technology - PR Newswire 02.11.13 | 04:02 am
- Ampio Pharmaceuticals Announces Participation At Upcoming Investor Conference - PR Newswire 01.22.13 | 04:01 am
- Ampio Pharmaceuticals Announces Active IND For Optinaâ¿¢ For The Treatment Of Diabetic Macular Edema (DME) - PR Newswire 01.22.13 | 04:01 am
- Ampio Pharmaceuticals, Inc. (AMPE) Announces Appointment Of Josh Disbrow As Chief Operating Officer Effective December 15, 2012 - PR Newswire 11.28.12 | 04:11 am
Partner Headlines for AMPE
- Stocks Maintain Early Lead; Drugmakers Alexion, Regeneron Climb - Investor's Business Daily 04.02.13 | 12:04 pm
- BioPharma Stock Movers For Wednesday, August 29 - Seeking Alpha 08.29.12 | 09:08 am
- Ultimate Market Recap: Barclays Chairman Bows Out, ATPG Looking Slick - Wall St. Cheat Sheet 07.02.12 | 10:07 am
- Morning Market Movers - Benzinga 07.02.12 | 09:07 am
- Arena Pharma FADES Below $10 and 4 High Demand Stocks ATTRACTING Eyes - Wall St. Cheat Sheet 07.02.12 | 02:07 am
- Weekly Market Wrap: Stocks RALLY, Gold SPARKLES, Apple's New Products REVEALED - Wall St. Cheat Sheet 06.17.12 | 12:06 pm
- Company News for June 12, 2012 - Corporate Summary - Zacks 06.12.12 | 10:06 am
- These 5 Small Cap Stocks Are Up Better Than 10% Today - Benzinga 06.11.12 | 01:06 pm
- 4 Contrarian Stock Climbers in Trading Action as Centene Falls Hard - Wall St. Cheat Sheet 06.11.12 | 01:06 pm
- Market Wrap: Gold GLITTERS as Apple's Innovation is Analyzed - Wall St. Cheat Sheet 06.11.12 | 10:06 am
